| Table 2: Identified pharmacogenes in ADHD and asthma. |
| | | Gene | Variants |
| | Asthma | ADRB2 | p.Arg16Gly, p.Gln27Glu | | AC9 | p.Ile772Met | | CRHR1 | c.122-1310C > A (intronic) | | TBX21 | p.His33Gln | | LTC4S | g.24030224A > C (promotor) | | CYSLTR1 | p.Phe309Phe | | ALOX5 | 5′ UTR | | GSDML | c.236-1199G > A (intronic) |
| | ADHD | DRD4 | 48 bp allele | | DAT1 | 3′ UTR | | 5-HTT | del-1212-1255 (promotor) | | SNAP-25 | 3′ UTR | | COMT | p.Val158Met | | ADRA2A | g.31585029G > C |
|
|
ADRB2: agonists of beta-2 adrenergic receptor; AC9: adenylyl cyclase type 9; CRHR1: corticotropin releasing hormone receptor 1; TBX21: T-box 21; LTC4S: leukotriene C4 synthase; CYSLTR1: cysteinyl leukotriene receptor 1; ALOX5: arachidonate 5-lipoxygenase; GSDML: gasdermin B; DRD4: dopamine receptor 4; DAT1: dopamine transporter 1; 5-HTT: serotonin transporter; SNAP-25: synaptosomal-associated protein; COMT: catechol-O-methyltransferase; ADRA2A: adrenergic alpha2-receptor; UTR: untranslated region.
|